Investing in new emerging technology, biotech, and social impact projects globally.
While stock markets are facing historically high volatility, private markets appear more attractive than ever as a great diversification asset class. We invest in companies aiming to shape tomorrow's world by identifying unique market opportunities. We have our roots in technology and telecom but are stage and vertical agnostic investing from Seed to pre-IPO crossover. To do so we leverage our existing ties with leading family offices and mid-sized hedge funds.
Having founded, grew, and sold leading companies in Switzerland we understand what it takes to build a successful business. Being entrepreneurs at heart, we value the human component of a company, and we look to work closely with founders of our portfolio companies. With over 50 years of combined experience in the technology and telecom sectors, we have built an extensive international network which we aim to open to our portfolio companies.
Want to collaborate? Contact UsCURRENT PORTFOLIO
COMPANY
COUNTRY OF ORIGIN
 COMPANY
COMPANY HAVING
 IPOED LTM
Samsara Therapeutics is biopharmaceutical company aiming to discover first-in-class therapeutics that treat rare genetic and neurodegenerative disease, and extend healthy lifespan.
View MoreAlto Neuroscience is a clinical-stage biopharmaceutical company that integrates the biology of the patient into drug development to improve the lives of people with mental health conditions.
View More1091 Bourg-en-lavaux,
SWITZERLAND